Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS).

Under Cox regression hazard (multivariate) analysis, factors associated with shorter OS were older age at treatment start, higher WBC counts (borderline significance), higher BM blasts, worse WHO-defined performance status, achievement of MiR or no response, shorter interval between initial diagnosis and lenalidomide treatment start, and complete transfusion dependency at baseline ( Table 6 ). 3.9.

also in 7,017 other papers